丹参黄芪注射液合用治疗冠心病心绞痛的疗效观察

摘要

Objective:To observe the clinical efficacy of Danshen Huangqi injection combined in the treatment of angina pectoris. In our hospital from May 2008 to March 2010, 66 patients with angina pectoris were randomly divided into three groups A, B, C, respectively, given Danshen injection, injection, Salvia Astragalus injection combined and to observe the efficacy and angina pectoris. Results: Danshen injection group, Astragalus injection group and Danshen Huangqi injection combined group treatment efficiency of 81.82%, 77.27%and 95.45%, respectively, significantly better than Salvia Salvia Astragalus injection combined angina pain and ECG efficacy injection Astragalus injection alone. Discussion: Salvia Astragalus injection combined for angina pectoris is superior to both single with no apparent side effects, worthy of promotion.%　　目的：观察丹参黄芪注射液合用在治疗冠心病心绞痛方面的临床疗效.方法：将2008年5月~2010年3月在本院收治的66名冠心病心绞痛患者随机分成A、B、C三组，分别给予丹参注射液，黄芪注射液，丹参黄芪注射液合用，并观察各组疗效以及心绞痛发作情况.结果：丹参注射液组、黄芪注射液组以及丹参黄芪注射液合用组治疗有效率分别为81.82%、77.27%和95.45%，丹参黄芪注射液合用对心绞痛患者疼痛的影响以及心电图疗效明显优于丹参注射液以及黄芪注射液单用.讨论：丹参黄芪注射液合用对于冠心病心绞痛的疗效明显优于两者单用，无明显毒副作用，值得临床推广.